• 2028: Q&A with hVIVO CEO, Mo Khan

  • Jan 29 2025
  • Durée: 12 min
  • Podcast

2028: Q&A with hVIVO CEO, Mo Khan

  • Résumé

  • Exciting times for the company as we sit down with Mo to discuss a record-breaking FY24, the game-changing acquisition of two clinical research units from CRS, and the strategic vision driving future growth. Mo shares insights on the synergies behind the CRS deal, the growing order book, and the evolving £40m pipeline of opportunities. Plus, we explore what’s next for the company’s M&A strategy. Don’t miss this deep dive into a company on the rise!”
    Voir plus Voir moins

Ce que les auditeurs disent de 2028: Q&A with hVIVO CEO, Mo Khan

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.